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In this issue of Immunity, Gomez-Rodriguez et al. (2009) demonstrate that signaling via the Itk kinase,
a component of the T cell receptor signaling pathway, is required for interleukin-17A but not interleukin-
17F expression in T helper 17 cells.The field of T cell signaling is replete with
examples demonstrating that differences
in T cell receptor (TCR) signal strength
give rise to remarkably distinct biological
and functional outcomes. Most dramati-
cally, the life or death fate of a developing
T cell in the thymus is determined by
‘‘weak’’ versus ‘‘strong’’ TCR engage-
ment, leading to positive versus negative
selection, respectively. Beyond T cell
development, the differentiation of CD4+
T cell effector lineages T helper 1 (Th1)
versus Th2 can also be manipulated by
altering the strength of TCR stimulation.
In this issue of Immunity, Gomez-Rodri-
guez and colleagues report an even more
subtle role for TCR signal strength in regu-
lating the differentiation of Th17 effector
T cells, by showing a clear distinction
between IL-17A and IL-17F expression
that is dependent on the Tec family tyro-
sine kinase Itk.
Itk is a nonreceptor tyrosine kinase that
functions downstream of the TCR to
phosphorylate and activate the signaling
molecule phospholipase C-g1 (PLC-g1)
(Berg et al., 2005). Thus, in the absence
of Itk, all of the inositol trisphosphate
(IP3)- and diacylglycerol (DAG)-depen-
dent pathways leading to transcription
factor activation are impaired. However,
the most substantial defect observed in
Itk/ T cells is a dramatic blunting of the
TCR-induced rise in cytosolic Ca+2, and
as a consequence, greatly impaired acti-
vation of a calcium-dependent transcrip-
tion factor, nuclear factor of activated
T cells (NFAT). The general outcome of
this biochemical deficiency is that Itk/
T cells are in fact activated by TCR stimu-
lation, but their responses are reduced in
magnitude relative to wild-type T cells.
For example, naive Itk/ T cells produce
less interleukin-2 (IL-2) and proliferateless robustly than wild-type T cells, and
effector T cells lacking Itk produce mark-
edly lower amounts of effector cytokines.
The remarkable aspect of this seem-
ingly inconsequential signaling deficiency
is the impact it has on numerous develop-
mental and differentiation pathways. As
first described by Fowell and colleagues
exactly 10 years ago, Itk/ CD4+ T cells
have a defect inmounting Th2 cell effector
responses to infections, yet are able to
generate protective immunity to patho-
gens that are cleared by Th1 cell effector
responses (Fowell et al., 1999). More
recently, several studies have docu-
mented that T cell development in the
absence of Itk generates predominantly
innate-like CD8+ T cells rather than the
conventional naive CD8+ T cells found in
wild-type mice (Berg, 2007). Gomez-
Rodriguez and colleagues now add an
even more intriguing example to this list
by demonstrating that Th17 cell differenti-
ation of Itk/ CD4+ T cells produces
effector cells that make robust amounts
of IL-17F but that are impaired in their
ability to produce IL-17A. Furthermore,
and even more importantly, the authors
provide a mechanistic explanation for
the disparity between IL-17A and IL-17F
expression that elegantly illustrates how
differences in proximal TCR signaling
components can be translated into
distinct functional outcomes.
In this report, Gomez-Rodriguez exam-
ined whether naive CD4+ T cells lacking
Itk can differentiate in vitro into Th17
effector cells. They used routine condi-
tions, such as TCR plus CD28 stimulation
in the presence of TGF-b and IL-6 (Korn
et al., 2009). Whereas Itk/ T cells upre-
gulated the key transcription factors, reti-
noid-related orphan receptor (ROR)gt and
RORa, similarly to wild-type T cells underImmunity 31these conditions, the Itk-deficient T cells
showed markedly reduced production of
IL-17A when restimulated. The authors
ruled out aberrant T cell development as
an explanation for this defect, given that
reintroduction of Itk into the Itk/ T cells
restored their ability to produce IL-17A.
Most surprisingly, though, was the finding
that restimulation of Itk/ Th17 cells with
pharmacological agents phorbol myris-
tate acetate (PMA) plus ionomycin, which
will bypass the requirement for Itk in TCR
signaling, was not able to restore IL-17A
production to the Th17 cells that had
differentiated in the absence of Itk. This
defect in the capacity to produce IL-17A
was exquisitely selective, given that Itk/
Th17 cells were able to make IL-17F,
IL-21, and IL-22 at amounts comparable
to those from wild-type Th17 cells. To
demonstrate the physiological signifi-
cance of this defect, and its relevance
in vivo, the authors went on to show that
induction of T cell-dependent airway
hyperresponsiveness led to impaired IL-
17A but normal IL-17F production in lungs
of Itk/ versus wild-type mice.
What, then, is the mechanistic basis of
this selective defect in IL-17A production
by Itk/ Th17 cells? To examine this
issue, Gomez-Rodriguez and colleagues
first considered whether Itk was required
for signaling via the cytokine receptors
that promote Th17 cell differentiation,
the TGF-b receptor and IL-6 receptor.
Because naive Itk/ CD4+ T cells were
able to upregulate FoxP3 normally when
activated in the presence of TGF-b and
IL-2, no defects in TGF-b receptor
signaling were implicated. In contrast,
Itk/ T cells appeared to have a modest
impairment in IL-6 receptor signaling
compared to wild-type T cells, as indi-
















Figure 1. ITK Signaling Regulates IL-17A Production via Activation of NFAT
Th17 differentiation is induced following activation of naive CD4+ T cells through their TCR plus the recep-
tors for IL-6 and TGF-b. The cytokine receptor signals activate STAT3 and promote the upregulation of
RORgt and RORa, key transcription factors in Th17 differentiation. Gomez-Rodriguez show that TCR
signaling leading to ITK activation is critical for IL-17A expression. ITK signaling induces calcium elevation,
leading to activation of NFAT and translocation of NFAT to the nucleus. Activated NFAT binds to the
IL-17A, but not the IL-17F promoter. The dependence of IL-17A transcription on NFAT may result from
a positive feedback loop whereby NFAT induces its own upregulation (A), or by a requirement for NFAT
in chromatin remodeling at the IL-17A locus (B), or a combination of the two mechanisms. Images were
provided by Motifolio Inc.stimulation with IL-6 in combination with
a variety of other cytokines, as well as
by the observation of slightly reduced
signal transducer and activator of tran-
scription (STAT)3 phosphorylation after
direct IL-6 stimulation. Nonetheless,
reduced STAT3 activation did not appear
to account for the defect in IL-17A
production by Itk/ Th17 cells, given
that introduction of a constitutively active
form of STAT3 to Itk/ T cells could not
restore their ability to differentiate into
IL-17A-secreting Th17 cells.
Instead, using a variety of independent
approaches that together present a
compelling illustration of this mecha-
nism, Gomez-Rodriguez and colleagues
showed that the well-known calcium
defect caused by the absence of Itk is
responsible for the substantial reduction
in IL-17A production by Itk/ T cells.
First, the authors showed that initial stim-
ulation of the Itk/ T cells with anti-CD3
plus ionomycin provided all the signals530 Immunity 31, October 16, 2009 ª2009 Erequired for normal Th17 cell differentia-
tion in the absence of Itk. Second, they
demonstrated that wild-type CD4+
T cells undergoing Th17 cell differentia-
tion in the presence of the calcineurin
inhibitor FK506 were selectively impaired
in IL-17A production. Together, these
two experiments indicated a critical role
for the calcineurin and calcium-depen-
dent transcription factor NFAT in the
differentiation of Th17 cells into robust
producers of IL-17A. Thus, to clinch this
conclusion, Gomez-Rodriguez and col-
leagues showed that introduction of
a constitutively active form of NFATc1 to
Itk/ T cells did in fact restore the
capacity of these cells to produce wild-
type amounts of IL-17A.
These findings raised the interesting
issue of why NFAT activity was so essen-
tial for IL-17A expression relative to
IL-17F. In this regard, the authors noted
that, in spite of the close linkage of the
two genes in a single locus, the promoterlsevier Inc.region of the IL-17A gene contains a
conserved NFAT binding site that is
absent from the promoter region of IL-
17F. This binding site was shown to be
occupied by NFATc1 in wild-type Th17
cells, but not in Th17 cells generated from
Itk/ CD4+ T cell progenitors. Because
these findings suggested that NFATc1
might be a direct transcriptional activator
of the IL-17A but not the IL-17F promoter,
the authors tested and verified this
prediction by using reporter assays in
which constitutively active NFATc1 was
expressed together with plasmid con-
structs containing each of the IL-17 gene
promoter sequences.
However, the demonstration that NFAT
activation is necessary for IL-17A but not
IL-17F transcription cannot be the entire
explanation for the defects observed
with Itk/ T cells. If this was the case,
then Itk/ Th17 cell restimulation with
PMA plus ionomycin, a condition that
induces robust activation of NFAT, should
produce wild-type expression of IL-17A.
Because this is not what is seen, there
must be an additional aspect to the defec-
tive IL-17A production by Itk/ T cells.
More specifically, the data in this paper
indicate that NFAT activity is required
during Th17 cell differentiation in order
for the T cells to be competent to produce
IL-17A at later time points, a conclusion
that implicates an earlier requirement for
NFAT beyond a simple role in the tran-
scription of the IL-17A gene (see Figure 1).
What might this early function of NFAT
during Th17 cell differentiation be? Here,
we are left with speculation because
a detailed explanation of this role for
NFAT remains a subject for future investi-
gations. One obvious potential explana-
tion is that NFAT is required for chromatin
remodeling at the IL-17A locus, in addition
to its role in IL-17A transcription. To
address this possibility, Gomez-Rodri-
guez and colleagues examined histone
H3 acetylation at the IL-17 locus in wild-
type and Itk/ Th17 cells by chromatin
immunoprecipitation. These experiments
did not reveal any differences in the
degree of histone H3 acetylation between
the wild-type cells and those lacking Itk;
however, these results do not rule out an
alternative function of NFAT in chromatin
remodeling at the IL-17 locus, such as
a role in recruitment of a switching-defec-
tive-sucrose nonfermenting (SWI-SNF)-
like ATP-dependent remodeling enzyme,
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ingly, previous studies in T cells have
demonstrated an NFAT-dependent
recruitment of BRG1 to the Th2 cytokine
locus as a key step in Th2 cell differentia-
tion (Wurster and Pazin, 2008). Further-
more, during Th1 cell differentiation,
TCR signaling is required for the recruit-
ment of BRG1 to the IL-12Rb2 locus
(Letimier et al., 2007), and in addition,
NFAT activity is specifically required for
nucleosome repositioning and recruit-
ment of BRG1 to the interferon (IFN)-g
locus (Zhang and Boothby, 2006). On
the basis of these precedents, it remains
possible that NFAT activity promotes an
additional aspect of chromatin remodel-
ing at the IL-17 locus during Th17 cell
differentiation than is evident by the anal-
ysis of histone H3 acetylation. Because
this aspect of chromatin remodeling is
often dependent on the combined action
of NFAT plus a STAT protein, the modest
defect in STAT3 activation in Itk/ T cells
may further contribute to an overall defect
in nucleosome repositioning or another
aspect of chromatin remodeling.
Alternatively, NFAT may have a totally
distinct and more indirect role in Th17 cellA View to a Kill: H
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In this issue of Immunity, Beal et al.
support synapse formation and mic
inability to recruit lytic granules to t
In the context of an infection, cytolytic
immune cells of an appropriate speci-
ficity are initially rare and must act as
highly efficient serial killers in order to
outpace the propagating pathogen and
minimize harm to the host. Although the
architecture of the cytolytic immune
synapse is well suited to the efficient and
selective killing of antigen-bearing targetdifferentiation. As discussed by Gomez-
Rodriguez and colleagues, NFATc1 is
normally upregulated after naive T cell
activation by a positive feedback loop that
requires initial NFAT activation (Nurieva
et al., 2007). Thus, when naive Itk/
T cells are stimulated through their TCR
plus CD28, the reduced activation of
NFAT in these cells would preclude the
normal upregulation of NFATc1. As a
consequence, Itk/ Th17 cells may not
express comparable amounts of NFATc1
protein as their wild-type counterparts,
thereby accounting for their failure to
express IL-17A after restimulation with
PMA plus ionomycin. This explanation
has appeal, given that it would readily
account for the disparity in IL-17A versus
IL-17F production by Itk/ Th17 cells,
a finding that is more difficult to attribute
to potential defects in chromatin remodel-
ing at this locus.
Regardless of the precise mechanism
by which NFAT activity selectively pro-
motes IL-17A production during Th17
cell differentiation, these findings by
Gomez-Rodriguez clearly illustrate the
intricate nuances of T cell differentiation,
and more importantly, the finesse withow Ligand
ethal Hits
hool of Medicine, Boston, MA 02111, USA
(2009) and Jenkins et al. (2009) dem
rotubule polarization, but fail to trig
he synaptic cleft.
cells, the mechanisms that regulate
antigen-dependent cytolysis are not fully
understood (Stinchcombe and Griffiths,
2007).
The boundary of the cytolytic immune
synapse consists of an integrin-rich
domain analogous to a peripheral supra-
molecular activation complex (pSMAC).
This adhesive ring surrounds a central
Immunity 3which apparently subtle alterations in
TCR signaling can have profound impact
on gene expression, and thus ultimately,
on T cell effector functions.
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